NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 3 filers reported holding NABRIVA THERAPEUTICS PLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $38,000 | -20.8% | 72,010 | 0.0% | 0.00% | – |
| Q2 2020 | $48,000 | +17.1% | 72,010 | 0.0% | 0.00% | – |
| Q1 2020 | $41,000 | -53.4% | 72,010 | +7.2% | 0.00% | – |
| Q4 2019 | $88,000 | -34.3% | 67,160 | +0.2% | 0.00% | -100.0% |
| Q3 2019 | $134,000 | -14.6% | 67,010 | +3.1% | 0.00% | 0.0% |
| Q2 2019 | $157,000 | +28.7% | 65,010 | +30.0% | 0.00% | 0.0% |
| Q1 2019 | $122,000 | +50.6% | 50,010 | -10.7% | 0.00% | – |
| Q4 2018 | $81,000 | -40.0% | 56,010 | +12.0% | 0.00% | -100.0% |
| Q3 2018 | $135,000 | -22.4% | 50,010 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $174,000 | -30.7% | 50,010 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $251,000 | -16.1% | 50,010 | 0.0% | 0.00% | -50.0% |
| Q4 2017 | $299,000 | – | 50,010 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 191,028 | $462,000 | 0.08% |
| Sterling Investment Advisors, Ltd. | 5,000 | $12,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |